APO Research

APO RESEARCH · REPORT

Yeast Expression Vector

Selected research

Industry Research

Yeast Expression Vector Industry Research Report 2026

Market perspective

The global Yeast Expression Vector market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Yeast Expression Vector is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Yeast Expression Vector is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Yeast Expression Vector is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Yeast Expression Vector include Thermo Fisher Scientific, Inc. (US), Sigma-Aldrich Corporation (US), QIAGEN (Netherlands), Promega Corporation (US), New England Biolabs (US), Merck Millipore (US), GenScript USA Inc. (US), DNA2.0 (US) and Clontech Laboratories, Inc. (US), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Yeast Expression Vector market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Yeast Expression Vector Market by Company

Thermo Fisher Scientific, Inc. (US)

Sigma-Aldrich Corporation (US)

QIAGEN (Netherlands)

Promega Corporation (US)

New England Biolabs (US)

Merck Millipore (US)

GenScript USA Inc. (US)

DNA2.0 (US)

Clontech Laboratories, Inc. (US)

Bio-Rad Laboratories (US)

Agilent Technologies (US)

Yeast Expression Vector Segment by Type

Saccharomyces Cerevisiae Expression Vectors

Pichia Pastoris Expression Vectors

K. Lactis Expression Vectors

Others

Yeast Expression Vector Segment by Application

Industrial

Research

Therapeutic

Yeast Expression Vector Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Yeast Expression Vector market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Yeast Expression Vector and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Yeast Expression Vector.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Yeast Expression Vector manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Yeast Expression Vector by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Yeast Expression Vector in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Yeast Expression Vector Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Yeast Expression Vector Sales (k units) of Manufacturers (2021-2026) Table 7. Global Yeast Expression Vector Sales Market Share by Manufacturers (2021-2026) Table 8. Global Yeast Expression Vector Revenue of Manufacturers (2021-2026) Table 9. Global Yeast Expression Vector Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Yeast Expression Vector Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Yeast Expression Vector Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Yeast Expression Vector, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Yeast Expression Vector, Product Type & Application Table 14. Global Yeast Expression Vector Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Yeast Expression Vector by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Thermo Fisher Scientific, Inc. (US) Company Information Table 19. Thermo Fisher Scientific, Inc. (US) Business Overview Table 20. Thermo Fisher Scientific, Inc. (US) Yeast Expression Vector Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Thermo Fisher Scientific, Inc. (US) Yeast Expression Vector Product Portfolio Table 22. Thermo Fisher Scientific, Inc. (US) Recent Developments Table 23. Sigma-Aldrich Corporation (US) Company Information Table 24. Sigma-Aldrich Corporation (US) Business Overview Table 25. Sigma-Aldrich Corporation (US) Yeast Expression Vector Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Sigma-Aldrich Corporation (US) Yeast Expression Vector Product Portfolio Table 27. Sigma-Aldrich Corporation (US) Recent Developments Table 28. QIAGEN (Netherlands) Company Information Table 29. QIAGEN (Netherlands) Business Overview Table 30. QIAGEN (Netherlands) Yeast Expression Vector Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. QIAGEN (Netherlands) Yeast Expression Vector Product Portfolio Table 32. QIAGEN (Netherlands) Recent Developments Table 33. Promega Corporation (US) Company Information Table 34. Promega Corporation (US) Business Overview Table 35. Promega Corporation (US) Yeast Expression Vector Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Promega Corporation (US) Yeast Expression Vector Product Portfolio Table 37. Promega Corporation (US) Recent Developments Table 38. New England Biolabs (US) Company Information Table 39. New England Biolabs (US) Business Overview Table 40. New England Biolabs (US) Yeast Expression Vector Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. New England Biolabs (US) Yeast Expression Vector Product Portfolio Table 42. New England Biolabs (US) Recent Developments Table 43. Merck Millipore (US) Company Information Table 44. Merck Millipore (US) Business Overview Table 45. Merck Millipore (US) Yeast Expression Vector Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Merck Millipore (US) Yeast Expression Vector Product Portfolio Table 47. Merck Millipore (US) Recent Developments Table 48. GenScript USA Inc. (US) Company Information Table 49. GenScript USA Inc. (US) Business Overview Table 50. GenScript USA Inc. (US) Yeast Expression Vector Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. GenScript USA Inc. (US) Yeast Expression Vector Product Portfolio Table 52. GenScript USA Inc. (US) Recent Developments Table 53. DNA2.0 (US) Company Information Table 54. DNA2.0 (US) Business Overview Table 55. DNA2.0 (US) Yeast Expression Vector Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. DNA2.0 (US) Yeast Expression Vector Product Portfolio Table 57. DNA2.0 (US) Recent Developments Table 58. Clontech Laboratories, Inc. (US) Company Information Table 59. Clontech Laboratories, Inc. (US) Business Overview Table 60. Clontech Laboratories, Inc. (US) Yeast Expression Vector Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Clontech Laboratories, Inc. (US) Yeast Expression Vector Product Portfolio Table 62. Clontech Laboratories, Inc. (US) Recent Developments Table 63. Bio-Rad Laboratories (US) Company Information Table 64. Bio-Rad Laboratories (US) Business Overview Table 65. Bio-Rad Laboratories (US) Yeast Expression Vector Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Bio-Rad Laboratories (US) Yeast Expression Vector Product Portfolio Table 67. Bio-Rad Laboratories (US) Recent Developments Table 68. Agilent Technologies (US) Company Information Table 69. Agilent Technologies (US) Business Overview Table 70. Agilent Technologies (US) Yeast Expression Vector Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Agilent Technologies (US) Yeast Expression Vector Product Portfolio Table 72. Agilent Technologies (US) Recent Developments Table 73. Global Yeast Expression Vector Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 74. Global Yeast Expression Vector Sales by Region (2021-2026) & (k units) Table 75. Global Yeast Expression Vector Sales Market Share by Region (2021-2026) Table 76. Global Yeast Expression Vector Sales by Region (2027-2032) & (k units) Table 77. Global Yeast Expression Vector Sales Market Share by Region (2027-2032) Table 78. Global Yeast Expression Vector Revenue by Region (2021-2026) & (US$ Million) Table 79. Global Yeast Expression Vector Revenue Market Share by Region (2021-2026) Table 80. Global Yeast Expression Vector Revenue by Region (2027-2032) & (US$ Million) Table 81. Global Yeast Expression Vector Revenue Market Share by Region (2027-2032) Table 82. North America Yeast Expression Vector Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. North America Yeast Expression Vector Sales by Country (2021-2026) & (k units) Table 84. North America Yeast Expression Vector Sales by Country (2027-2032) & (k units) Table 85. North America Yeast Expression Vector Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Yeast Expression Vector Revenue by Country (2027-2032) & (US$ Million) Table 87. Europe Yeast Expression Vector Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Europe Yeast Expression Vector Sales by Country (2021-2026) & (k units) Table 89. Europe Yeast Expression Vector Sales by Country (2027-2032) & (k units) Table 90. Europe Yeast Expression Vector Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Yeast Expression Vector Revenue by Country (2027-2032) & (US$ Million) Table 92. Asia Pacific Yeast Expression Vector Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Asia Pacific Yeast Expression Vector Sales by Country (2021-2026) & (k units) Table 94. Asia Pacific Yeast Expression Vector Sales by Country (2027-2032) & (k units) Table 95. Asia Pacific Yeast Expression Vector Revenue by Country (2021-2026) & (US$ Million) Table 96. Asia Pacific Yeast Expression Vector Revenue by Country (2027-2032) & (US$ Million) Table 97. South America Yeast Expression Vector Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. South America Yeast Expression Vector Sales by Country (2021-2026) & (k units) Table 99. South America Yeast Expression Vector Sales by Country (2027-2032) & (k units) Table 100. South America Yeast Expression Vector Revenue by Country (2021-2026) & (US$ Million) Table 101. South America Yeast Expression Vector Revenue by Country (2027-2032) & (US$ Million) Table 102. Middle East and Africa Yeast Expression Vector Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Middle East and Africa Yeast Expression Vector Sales by Country (2021-2026) & (k units) Table 104. Middle East and Africa Yeast Expression Vector Sales by Country (2027-2032) & (k units) Table 105. Middle East and Africa Yeast Expression Vector Revenue by Country (2021-2026) & (US$ Million) Table 106. Middle East and Africa Yeast Expression Vector Revenue by Country (2027-2032) & (US$ Million) Table 107. Global Yeast Expression Vector Sales by Type (2021-2026) & (k units) Table 108. Global Yeast Expression Vector Sales by Type (2027-2032) & (k units) Table 109. Global Yeast Expression Vector Sales Market Share by Type (2021-2026) Table 110. Global Yeast Expression Vector Sales Market Share by Type (2027-2032) Table 111. Global Yeast Expression Vector Revenue by Type (2021-2026) & (US$ Million) Table 112. Global Yeast Expression Vector Revenue by Type (2027-2032) & (US$ Million) Table 113. Global Yeast Expression Vector Revenue Market Share by Type (2021-2026) Table 114. Global Yeast Expression Vector Revenue Market Share by Type (2027-2032) Table 115. Global Yeast Expression Vector Price by Type (2021-2026) & (US$/unit) Table 116. Global Yeast Expression Vector Price by Type (2027-2032) & (US$/unit) Table 117. Global Yeast Expression Vector Sales by Application (2021-2026) & (k units) Table 118. Global Yeast Expression Vector Sales by Application (2027-2032) & (k units) Table 119. Global Yeast Expression Vector Sales Market Share by Application (2021-2026) Table 120. Global Yeast Expression Vector Sales Market Share by Application (2027-2032) Table 121. Global Yeast Expression Vector Revenue by Application (2021-2026) & (US$ Million) Table 122. Global Yeast Expression Vector Revenue by Application (2027-2032) & (US$ Million) Table 123. Global Yeast Expression Vector Revenue Market Share by Application (2021-2026) Table 124. Global Yeast Expression Vector Revenue Market Share by Application (2027-2032) Table 125. Global Yeast Expression Vector Price by Application (2021-2026) & (US$/unit) Table 126. Global Yeast Expression Vector Price by Application (2027-2032) & (US$/unit) Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Yeast Expression Vector Distributors List Table 130. Yeast Expression Vector Customers List Table 131. Yeast Expression Vector Industry Trends Table 132. Yeast Expression Vector Industry Drivers Table 133. Yeast Expression Vector Industry Restraints Table 134. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Yeast Expression Vector Product Image Figure 5. Global Yeast Expression Vector Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Yeast Expression Vector Market Size (2021-2032) & (US$ Million) Figure 7. Global Yeast Expression Vector Sales (2021-2032) & (k units) Figure 8. Global Yeast Expression Vector Average Price (US$/unit) & (2021-2032) Figure 9. Saccharomyces Cerevisiae Expression Vectors Product Image Figure 10. Pichia Pastoris Expression Vectors Product Image Figure 11. K. Lactis Expression Vectors Product Image Figure 12. Others Product Image Figure 13. Industrial Product Image Figure 14. Research Product Image Figure 15. Therapeutic Product Image Figure 16. Global Yeast Expression Vector Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Yeast Expression Vector, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Yeast Expression Vector Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Yeast Expression Vector Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Yeast Expression Vector Sales by Region in 2025 Figure 22. Global Yeast Expression Vector Revenue by Region in 2025 Figure 23. North America Yeast Expression Vector Market Size by Country in 2025 Figure 24. North America Yeast Expression Vector Sales Market Share by Country (2021-2032) Figure 25. North America Yeast Expression Vector Revenue Market Share by Country (2021-2032) Figure 26. United States Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Yeast Expression Vector Market Size by Country in 2025 Figure 30. Europe Yeast Expression Vector Sales Market Share by Country (2021-2032) Figure 31. Europe Yeast Expression Vector Revenue Market Share by Country (2021-2032) Figure 32. Germany Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Yeast Expression Vector Market Size by Country in 2025 Figure 43. Asia Pacific Yeast Expression Vector Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Yeast Expression Vector Revenue Market Share by Country (2021-2032) Figure 45. China Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Yeast Expression Vector Market Size by Country in 2025 Figure 54. South America Yeast Expression Vector Sales Market Share by Country (2021-2032) Figure 55. South America Yeast Expression Vector Revenue Market Share by Country (2021-2032) Figure 56. Brazil Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Colombia Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Yeast Expression Vector Market Size by Country in 2025 Figure 61. Middle East and Africa Yeast Expression Vector Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Yeast Expression Vector Revenue Market Share by Country (2021-2032) Figure 63. Egypt Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Yeast Expression Vector Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Yeast Expression Vector Sales Market Share by Type (2021-2032) Figure 69. Global Yeast Expression Vector Revenue Market Share by Type (2021-2032) Figure 70. Global Yeast Expression Vector Price (US$/unit) by Type (2021-2032) Figure 71. Global Yeast Expression Vector Sales Market Share by Application (2021-2032) Figure 72. Global Yeast Expression Vector Revenue Market Share by Application (2021-2032) Figure 73. Global Yeast Expression Vector Price (US$/unit) by Application (2021-2032) Figure 74. Yeast Expression Vector Value Chain Figure 75. Yeast Expression Vector Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Yeast Expression Vector Industry Opportunities and Challenges

Scope & coverage.

Types
  • Saccharomyces Cerevisiae Expression Vectors
  • Pichia Pastoris Expression Vectors
  • K. Lactis Expression Vectors
  • Others
Applications
  • Industrial
  • Research
  • Therapeutic
Companies covered
  • Thermo Fisher Scientific, Inc. (US)
  • Sigma-Aldrich Corporation (US)
  • QIAGEN (Netherlands)
  • Promega Corporation (US)
  • New England Biolabs (US)
  • Merck Millipore (US)
  • GenScript USA Inc. (US)
  • DNA2.0 (US)
  • Clontech Laboratories, Inc. (US)
  • Bio-Rad Laboratories (US)
  • Agilent Technologies (US)

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Yeast Expression Vector Market Size (2021-2032)
  4. 2.2.2 Global Yeast Expression Vector Sales (2021-2032)
  5. 2.2.3 Global Yeast Expression Vector Market Average Price (2021-2032)
  6. 2.3 Yeast Expression Vector by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Saccharomyces Cerevisiae Expression Vectors
  9. 2.3.3 Pichia Pastoris Expression Vectors
  10. 2.3.4 K. Lactis Expression Vectors
  11. 2.3.5 Others
  12. 2.4 Yeast Expression Vector by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Industrial
  15. 2.4.3 Research
  16. 2.4.4 Therapeutic
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Yeast Expression Vector Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Yeast Expression Vector Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Yeast Expression Vector Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Yeast Expression Vector Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Yeast Expression Vector Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Yeast Expression Vector, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Yeast Expression Vector, Product Type & Application
  8. 3.8 Global Manufacturers of Yeast Expression Vector, Established Date
  9. 3.9 Global Yeast Expression Vector Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Thermo Fisher Scientific, Inc. (US)
  2. 4.1.1 Thermo Fisher Scientific, Inc. (US) Company Information
  3. 4.1.2 Thermo Fisher Scientific, Inc. (US) Business Overview
  4. 4.1.3 Thermo Fisher Scientific, Inc. (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Thermo Fisher Scientific, Inc. (US) Yeast Expression Vector Product Portfolio
  6. 4.1.5 Thermo Fisher Scientific, Inc. (US) Recent Developments
  7. 4.2 Sigma-Aldrich Corporation (US)
  8. 4.2.1 Sigma-Aldrich Corporation (US) Company Information
  9. 4.2.2 Sigma-Aldrich Corporation (US) Business Overview
  10. 4.2.3 Sigma-Aldrich Corporation (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Sigma-Aldrich Corporation (US) Yeast Expression Vector Product Portfolio
  12. 4.2.5 Sigma-Aldrich Corporation (US) Recent Developments
  13. 4.3 QIAGEN (Netherlands)
  14. 4.3.1 QIAGEN (Netherlands) Company Information
  15. 4.3.2 QIAGEN (Netherlands) Business Overview
  16. 4.3.3 QIAGEN (Netherlands) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 QIAGEN (Netherlands) Yeast Expression Vector Product Portfolio
  18. 4.3.5 QIAGEN (Netherlands) Recent Developments
  19. 4.4 Promega Corporation (US)
  20. 4.4.1 Promega Corporation (US) Company Information
  21. 4.4.2 Promega Corporation (US) Business Overview
  22. 4.4.3 Promega Corporation (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Promega Corporation (US) Yeast Expression Vector Product Portfolio
  24. 4.4.5 Promega Corporation (US) Recent Developments
  25. 4.5 New England Biolabs (US)
  26. 4.5.1 New England Biolabs (US) Company Information
  27. 4.5.2 New England Biolabs (US) Business Overview
  28. 4.5.3 New England Biolabs (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 New England Biolabs (US) Yeast Expression Vector Product Portfolio
  30. 4.5.5 New England Biolabs (US) Recent Developments
  31. 4.6 Merck Millipore (US)
  32. 4.6.1 Merck Millipore (US) Company Information
  33. 4.6.2 Merck Millipore (US) Business Overview
  34. 4.6.3 Merck Millipore (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Merck Millipore (US) Yeast Expression Vector Product Portfolio
  36. 4.6.5 Merck Millipore (US) Recent Developments
  37. 4.7 GenScript USA Inc. (US)
  38. 4.7.1 GenScript USA Inc. (US) Company Information
  39. 4.7.2 GenScript USA Inc. (US) Business Overview
  40. 4.7.3 GenScript USA Inc. (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 GenScript USA Inc. (US) Yeast Expression Vector Product Portfolio
  42. 4.7.5 GenScript USA Inc. (US) Recent Developments
  43. 4.8 DNA2.0 (US)
  44. 4.8.1 DNA2.0 (US) Company Information
  45. 4.8.2 DNA2.0 (US) Business Overview
  46. 4.8.3 DNA2.0 (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 DNA2.0 (US) Yeast Expression Vector Product Portfolio
  48. 4.8.5 DNA2.0 (US) Recent Developments
  49. 4.9 Clontech Laboratories, Inc. (US)
  50. 4.9.1 Clontech Laboratories, Inc. (US) Company Information
  51. 4.9.2 Clontech Laboratories, Inc. (US) Business Overview
  52. 4.9.3 Clontech Laboratories, Inc. (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Clontech Laboratories, Inc. (US) Yeast Expression Vector Product Portfolio
  54. 4.9.5 Clontech Laboratories, Inc. (US) Recent Developments
  55. 4.10 Bio-Rad Laboratories (US)
  56. 4.10.1 Bio-Rad Laboratories (US) Company Information
  57. 4.10.2 Bio-Rad Laboratories (US) Business Overview
  58. 4.10.3 Bio-Rad Laboratories (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Bio-Rad Laboratories (US) Yeast Expression Vector Product Portfolio
  60. 4.10.5 Bio-Rad Laboratories (US) Recent Developments
  61. 4.11 Agilent Technologies (US)
  62. 4.11.1 Agilent Technologies (US) Company Information
  63. 4.11.2 Agilent Technologies (US) Business Overview
  64. 4.11.3 Agilent Technologies (US) Yeast Expression Vector Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Agilent Technologies (US) Yeast Expression Vector Product Portfolio
  66. 4.11.5 Agilent Technologies (US) Recent Developments
5 Global Yeast Expression Vector Market Scenario by Region
  1. 5.1 Global Yeast Expression Vector Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Yeast Expression Vector Sales by Region: 2021-2032
  3. 5.2.1 Global Yeast Expression Vector Sales by Region: 2021-2026
  4. 5.2.2 Global Yeast Expression Vector Sales by Region: 2027-2032
  5. 5.3 Global Yeast Expression Vector Revenue by Region: 2021-2032
  6. 5.3.1 Global Yeast Expression Vector Revenue by Region: 2021-2026
  7. 5.3.2 Global Yeast Expression Vector Revenue by Region: 2027-2032
  8. 5.4 North America Yeast Expression Vector Market Facts & Figures by Country
  9. 5.4.1 North America Yeast Expression Vector Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Yeast Expression Vector Sales by Country (2021-2032)
  11. 5.4.3 North America Yeast Expression Vector Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Yeast Expression Vector Market Facts & Figures by Country
  16. 5.5.1 Europe Yeast Expression Vector Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Yeast Expression Vector Sales by Country (2021-2032)
  18. 5.5.3 Europe Yeast Expression Vector Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Yeast Expression Vector Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Yeast Expression Vector Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Yeast Expression Vector Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Yeast Expression Vector Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Yeast Expression Vector Market Facts & Figures by Country
  41. 5.7.1 South America Yeast Expression Vector Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Yeast Expression Vector Sales by Country (2021-2032)
  43. 5.7.3 South America Yeast Expression Vector Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Yeast Expression Vector Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Yeast Expression Vector Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Yeast Expression Vector Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Yeast Expression Vector Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Yeast Expression Vector Sales by Type (2021-2032)
  2. 6.1.1 Global Yeast Expression Vector Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Yeast Expression Vector Sales Market Share by Type (2021-2032)
  4. 6.2 Global Yeast Expression Vector Revenue by Type (2021-2032)
  5. 6.2.1 Global Yeast Expression Vector Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Yeast Expression Vector Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Yeast Expression Vector Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Yeast Expression Vector Sales by Application (2021-2032)
  2. 7.1.1 Global Yeast Expression Vector Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Yeast Expression Vector Sales Market Share by Application (2021-2032)
  4. 7.2 Global Yeast Expression Vector Revenue by Application (2021-2032)
  5. 7.2.1 Global Yeast Expression Vector Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Yeast Expression Vector Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Yeast Expression Vector Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Yeast Expression Vector Value Chain Analysis
  2. 8.1.1 Yeast Expression Vector Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Yeast Expression Vector Production Mode & Process
  5. 8.2 Yeast Expression Vector Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Yeast Expression Vector Distributors
  8. 8.2.3 Yeast Expression Vector Customers
9 Global Yeast Expression Vector Analyzing Market Dynamics
  1. 9.1 Yeast Expression Vector Industry Trends
  2. 9.2 Yeast Expression Vector Industry Drivers
  3. 9.3 Yeast Expression Vector Industry Opportunities and Challenges
  4. 9.4 Yeast Expression Vector Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research